An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.

Citation data:

Gynecologic oncology, ISSN: 1095-6859, Vol: 147, Issue: 2, Page: 243-249

Publication Year:
2017
Usage 11
Abstract Views 9
Link-outs 2
Citations 1
Citation Indexes 1
PMID:
28807367
DOI:
10.1016/j.ygyno.2017.08.004
Author(s):
Oliver, Kate E, Brady, William E, Birrer, Michael, Gershenson, David M, Fleming, Gini, Copeland, Larry J, Tewari, Krishnansu, Argenta, Peter A, Mannel, Robert S, Secord, Angeles Alvarez, Stephan, Jean-Marie, Mutch, David G, Stehman, Frederick B, Muggia, Franco M, Rose, Peter G, Armstrong, Deborah K, Bookman, Michael A, Burger, Robert A, Farley, John H Show More Hide
Publisher(s):
Elsevier BV
Tags:
Medicine
article description
We examined disparities in prognosis between patients with ovarian clear cell carcinoma (OCCC) and serous epithelial ovarian cancer (SOC).

This article has 0 Wikipedia mention.